A2 Milk, the New Zealand dairy company known for its infant formula, announced that the supply constraints that disrupted availability of its China-label products are now "substantially resolved." The disruption had cut sales of that specific line by roughly 14%, but the company now expects a stronger fiscal 2026, with revenue of NZ$1.97 billion and net profit after tax slightly above last year's NZ$202.9 million.
What caused the supply squeeze?
In April, A2 Milk warned that low inventories were limiting how much of its China-label infant formula actually reached store shelves, even as consumer demand remained robust. The company also pointed to higher freight costs linked to conflict in the Middle East, which made replenishing stock more difficult and expensive. The combination of depleted inventory and rising shipping expenses created a bottleneck that hurt sales in one of its most important markets.
China-label formula is a key product for A2 Milk because it is sold directly through Chinese retail channels, often carrying higher margins than its English-label counterpart, which is typically sold through cross-border e-commerce or daigou (personal shopper) channels. The disruption therefore had an outsized impact on profitability.
How the recovery is playing out
Now that the supply constraints are resolved, A2 Milk says other product lines, including its English-label infant formula, held up well during the disruption. The improved outlook reflects both the recovery in China-label availability and the resilience of the broader portfolio.
The company's revised guidance calls for revenue of NZ$1.97 billion, representing 12% year-on-year growth, and net profit after tax slightly above the NZ$202.9 million reported in fiscal 2025. Earlier, the company had flagged the possibility of similar or lower earnings, so the upgrade signals confidence that the worst of the supply issues is behind it.
For context, A2 Milk's performance is closely tied to the Chinese infant formula market, which has been under pressure from falling birth rates and increased competition from local brands. However, the company has maintained a premium positioning, and its China-label products are seen as a bellwether for its ability to navigate regulatory and logistical challenges in the region. Relatedly, broader trends in Chinese consumer spending and inflation data can influence demand for premium imported goods, as seen in recent market moves China Stocks Dip as Investors Await June Inflation Data That Could Shape PBoC Policy.
What it means for investors
While the headline guidance is positive, investors should look beyond the top-line numbers. When a company fixes a supply bottleneck caused by low inventories, the next phase often involves rebuilding stock across retailers and distributors. That process runs through working capital—the cash tied up in day-to-day operations. More inventory in the system, and sometimes more money owed by customers, can soak up cash even while revenue and profit recover.
So while A2 Milk's guidance implies a cleaner earnings picture in fiscal 2026, its operating cash flow and cash conversion (how much profit turns into cash) can look softer during the restock period. For investors, that difference can shape how "high quality" the rebound feels, especially if inventory levels rise faster than consumer sales.
The key question from here is how quickly regained shelf space translates into steady sell-through, rather than a one-time restock spike. If retailers and distributors simply fill their warehouses but end consumers don't buy at the same pace, the company could face a buildup of inventory that later requires discounting or write-downs.
Additionally, freight costs remain elevated due to ongoing geopolitical tensions, and any further disruption in shipping routes could again pressure margins. The company's ability to manage these costs while rebuilding inventory will be closely watched. For a broader view of how supply chain issues are affecting other commodities, see Congo Copper and Cobalt Mines Weather Acid Supply Disruptions from Zambia.
Broader market context
A2 Milk's recovery comes against a backdrop of mixed signals in the New Zealand economy. Consumer spending has been flat, as indicated by recent data New Zealand Card Spending Flat in June as Hospitality Slumps, Tourism Rises, and the stock market has been hitting record highs, partly driven by energy and commodity stocks New Zealand Stocks Hit Record High as OPEC+ Boosts Oil Supply. For a dairy exporter like A2 Milk, the health of the Chinese consumer is paramount, and any signs of weakening demand there could offset the benefits of resolved supply issues.
Investors will also be watching the company's next earnings report for details on inventory levels, cash flow, and the pace of sell-through in China. The resolution of the supply bottleneck is a positive step, but the true test will be whether A2 Milk can sustain the momentum without sacrificing profitability.
